MAPT and Alzheimer disease: Here, we demonstrate that the TGF‐β1/Smad3 signaling pathway plays a critical role in regulating microglial phagocytic ability in removing Aβ and p‐tau aggregates, and more importantly, in reversing cognitive deficits during the advanced stage of AD.